To sum up, biological strategies that block specific immune mediators such as TNF-α or IL-1 are effective in suppressing TRAPS symptoms, preventing reactive amyloidosis, and halting the progression to organ damage. Here, IL1B is linked to TNF receptor 1-associated periodic fever syndrome.